does tirzepatide have fewer side effects than semaglutide vs. Semaglutide: Which Has Effects? Cardiovascular outcomes of semaglutide and

In selected patients, especially those with obesity, diabetes, metabolic syndrome or increased cardiovascular risk, GLP-1 receptor agonists may be worth considering or discussing as part of overall patient management. For more information: Beata Jastrzb-Mikiewicz , MD, PhD , is a dermatologist and venereologist at Wrocaw University of Science and Technology in Poland

This isnt about just adding another supplement

32.0 7.8, SMD = 0.39)

This process is vital for the proper functioning of muscles, but also the heart

"I would argue that in real life, these numbers are so, so small in terms of the amount of patients who could potentially benefit from the drug, whether for type 2 diabetes and/or obesity," Mangarelli said